Literature DB >> 8393392

Serial thallium-201 scintigraphy in osteosarcoma. Correlation with tumor necrosis after preoperative chemotherapy.

G Rosen1, G J Loren, E W Brien, L Ramana, A Waxman, S Lowenbraun, J J Eckardt, F Eilber, L Menendez, J M Mirra.   

Abstract

In 27 patients with extremity lesions (24 osteosarcoma, three malignant fibrous histiocytoma), a notable decrease in thallium-201 uptake was correlated with a good response to preoperative chemotherapy of the primary tumor. A good response is indicated by a greater than 95% tumor necrosis. Serial quantitative thallium-201 uptake of malignant bone tumors in patients receiving preoperative chemotherapy therefore can accurately predict a good histologic response and prognosis. Serial thallium scintigraphy can furthermore identify poor responses within two weeks after the initiation of treatment, or can prompt an early change in preoperative chemotherapy and facilitate limb salvage surgery.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393392

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  5 in total

Review 1.  Where are we with nuclear medicine in pediatrics?

Authors:  H R Nadel
Journal:  Eur J Nucl Med       Date:  1995-12

2.  Estimation of potential excess cancer incidence in pediatric 201Tl imaging.

Authors:  Sue C Kaste; George L Waszilycsak; M Beth McCarville; Najat C Daw
Journal:  AJR Am J Roentgenol       Date:  2010-01       Impact factor: 3.959

3.  Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma.

Authors:  J Lin; W T Leung; S K Ho; K C Ho; S M Kumta; C Metreweli; P J Johnson
Journal:  Eur J Nucl Med       Date:  1995-06

Review 4.  The role of SPET and PET in monitoring tumour response to therapy.

Authors:  Chariklia Giannopoulou
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-06-14       Impact factor: 9.236

5.  Prognostic value of radiological response to chemotherapy in patients with osteosarcoma.

Authors:  Shinji Miwa; Akihiko Takeuchi; Toshiharu Shirai; Junichi Taki; Norio Yamamoto; Hideji Nishida; Katsuhiro Hayashi; Yoshikazu Tanzawa; Hiroaki Kimura; Kentaro Igarashi; Akishi Ooi; Hiroyuki Tsuchiya
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.